Abivax (ABVX) EBITDA Margin (2024 - 2026)
Powered by 
Analysis
Abivax (ABVX) EBITDA Margin (2024 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,144.36 Bn | 1,112.95 Bn | 19.71 Bn | 53.49% |
| 2 | Johnson & Johnson | 635.36 Bn | 555.22 Bn | 17.30 Bn | 32.68% |
| 3 | AbbVie | 502.79 Bn | 475.90 Bn | 12.70 Bn | 49.01% |
| 4 | Merck | 356.08 Bn | 310.46 Bn | 12.21 Bn | 6.02% |
| 5 | Novartis Ag | 300.87 Bn | 264.86 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 264.31 Bn | 237.99 Bn | 12.86 Bn | 33.11% |
| 7 | Amgen | 239.07 Bn | 194.47 Bn | 7.24 Bn | 46.01% |
| 8 | Gilead Sciences | 194.50 Bn | 168.70 Bn | 6.22 Bn | -124.26% |
| 9 | Pfizer | 171.00 Bn | 117.64 Bn | 10.94 Bn | 39.16% |
| 10 | Abivax | 6.15 Bn | 3.79 Bn | - | -184.69% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -184.69% |
| Sep 30, 2025 | -83.43% |
| Jun 30, 2025 | -829.06% |
| Mar 31, 2025 | -2,177.59% |
| Dec 31, 2024 | -19,910.15% |
| Sep 30, 2024 | -477.61% |
| Jun 30, 2024 | -374.60% |
| Mar 31, 2024 | -657.50% |
API Access
Abivax EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=ABVX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "ABVX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=ABVX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();